Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Metal nanoparticles as a promising technology in targeted cancer treatment
by
Guo, Ya-Wen
, Zhang, Wan-Chen
, Chen, Xiao-Yi
, Xu, Jia-Jie
, Zhang, You-Ni
in
Antineoplastic Agents - pharmacology
/ Antineoplastic Agents - therapeutic use
/ Breast cancer
/ Cancer research
/ Cancer therapies
/ Cancer treatment
/ Cell division
/ Chemotherapy
/ Drug delivery systems
/ Drugs
/ Hospitals
/ Humans
/ hyperthermia
/ Laboratories
/ Ligands
/ Lung cancer
/ Medical research
/ Medical schools
/ Metal Nanoparticles
/ Nanoparticles
/ Nanotechnology
/ Neoplasms - drug therapy
/ Radiation
/ radiation therapy
/ Silver
/ Surgery
/ targeting
/ Technology
/ Tumors
2022
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Metal nanoparticles as a promising technology in targeted cancer treatment
by
Guo, Ya-Wen
, Zhang, Wan-Chen
, Chen, Xiao-Yi
, Xu, Jia-Jie
, Zhang, You-Ni
in
Antineoplastic Agents - pharmacology
/ Antineoplastic Agents - therapeutic use
/ Breast cancer
/ Cancer research
/ Cancer therapies
/ Cancer treatment
/ Cell division
/ Chemotherapy
/ Drug delivery systems
/ Drugs
/ Hospitals
/ Humans
/ hyperthermia
/ Laboratories
/ Ligands
/ Lung cancer
/ Medical research
/ Medical schools
/ Metal Nanoparticles
/ Nanoparticles
/ Nanotechnology
/ Neoplasms - drug therapy
/ Radiation
/ radiation therapy
/ Silver
/ Surgery
/ targeting
/ Technology
/ Tumors
2022
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Metal nanoparticles as a promising technology in targeted cancer treatment
by
Guo, Ya-Wen
, Zhang, Wan-Chen
, Chen, Xiao-Yi
, Xu, Jia-Jie
, Zhang, You-Ni
in
Antineoplastic Agents - pharmacology
/ Antineoplastic Agents - therapeutic use
/ Breast cancer
/ Cancer research
/ Cancer therapies
/ Cancer treatment
/ Cell division
/ Chemotherapy
/ Drug delivery systems
/ Drugs
/ Hospitals
/ Humans
/ hyperthermia
/ Laboratories
/ Ligands
/ Lung cancer
/ Medical research
/ Medical schools
/ Metal Nanoparticles
/ Nanoparticles
/ Nanotechnology
/ Neoplasms - drug therapy
/ Radiation
/ radiation therapy
/ Silver
/ Surgery
/ targeting
/ Technology
/ Tumors
2022
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Metal nanoparticles as a promising technology in targeted cancer treatment
Journal Article
Metal nanoparticles as a promising technology in targeted cancer treatment
2022
Request Book From Autostore
and Choose the Collection Method
Overview
Traditional anticancer treatments have several limitations, but cancer is still one of the deadliest diseases. As a result, new anticancer drugs are required for the treatment of cancer. The use of metal nanoparticles (NPs) as alternative chemotherapeutic drugs is on the rise in cancer research. Metal NPs have the potential for use in a wide range of applications. Natural or surface-induced anticancer effects can be found in metals. The focus of this review is on the therapeutic potential of metal-based NPs. The potential of various types of metal NPs for tumor targeting will be discussed for cancer treatment. The in vivo application of metal NPs for solid tumors will be reviewed. Risk factors involved in the clinical application of metal NPs will also be summarized.
Publisher
Taylor & Francis,Taylor & Francis Ltd,Taylor & Francis Group
Subject
This website uses cookies to ensure you get the best experience on our website.